Annual Total Liabilities
$22.42 M
+$1.08 M+5.06%
December 31, 2023
Summary
- As of February 7, 2025, EVGN annual total liabilities is $22.42 million, with the most recent change of +$1.08 million (+5.06%) on December 31, 2023.
- During the last 3 years, EVGN annual total liabilities has risen by +$7.38 million (+49.11%).
- EVGN annual total liabilities is now at all-time high.
Performance
EVGN Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$27.88 M
+$6.85 M+32.57%
September 1, 2024
Summary
- As of February 7, 2025, EVGN quarterly total liabilities is $27.88 million, with the most recent change of +$6.85 million (+32.57%) on September 1, 2024.
- Over the past year, EVGN quarterly total liabilities has increased by +$5.99 million (+27.39%).
- EVGN quarterly total liabilities is now at all-time high.
Performance
EVGN Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
EVGN Total Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +5.1% | +27.4% |
3 y3 years | +49.1% | +30.6% |
5 y5 years | +167.2% | +175.1% |
EVGN Total Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +74.0% | at high | +147.5% |
5 y | 5-year | at high | +101.1% | at high | +187.1% |
alltime | all time | at high | +172.6% | at high | +262.3% |
Evogene Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $27.88 M(+32.6%) |
Jun 2024 | - | $21.03 M(-1.7%) |
Mar 2024 | - | $21.40 M(-4.5%) |
Dec 2023 | $22.42 M(+5.1%) | $22.42 M(+2.4%) |
Sep 2023 | - | $21.88 M(-1.6%) |
Jun 2023 | - | $22.23 M(+6.0%) |
Mar 2023 | - | $20.98 M(-1.7%) |
Dec 2022 | $21.34 M(+65.6%) | $21.34 M(+1.2%) |
Sep 2022 | - | $21.09 M(+87.2%) |
Jun 2022 | - | $11.27 M(-7.3%) |
Mar 2022 | - | $12.15 M(-5.7%) |
Dec 2021 | $12.88 M(-14.3%) | $12.88 M(+2.0%) |
Sep 2021 | - | $12.63 M(+15.9%) |
Jun 2021 | - | $10.89 M(+2.1%) |
Mar 2021 | - | $10.67 M(-29.0%) |
Dec 2020 | $15.03 M(+34.9%) | $15.03 M(+51.6%) |
Sep 2020 | - | $9.91 M(-2.1%) |
Jun 2020 | - | $10.13 M(+4.4%) |
Mar 2020 | - | $9.71 M(-12.9%) |
Dec 2019 | $11.15 M(+32.9%) | $11.15 M(+8.1%) |
Sep 2019 | - | $10.31 M(-2.7%) |
Jun 2019 | - | $10.60 M(-2.6%) |
Mar 2019 | - | $10.88 M(+29.7%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2018 | $8.39 M(+2.0%) | $8.39 M(+6.3%) |
Sep 2018 | - | $7.89 M(-3.0%) |
Jun 2018 | - | $8.14 M(+5.6%) |
Mar 2018 | - | $7.70 M(-6.3%) |
Dec 2017 | $8.22 M(-5.4%) | $8.22 M(+1.5%) |
Sep 2017 | - | $8.10 M(-0.1%) |
Jun 2017 | - | $8.11 M(-5.6%) |
Mar 2017 | - | $8.59 M(-1.2%) |
Dec 2016 | $8.70 M(-1.7%) | $8.70 M(+2.3%) |
Sep 2016 | - | $8.50 M(+3.1%) |
Jun 2016 | - | $8.25 M(+7.2%) |
Mar 2016 | - | $7.70 M(-13.0%) |
Dec 2015 | $8.84 M(-23.1%) | $8.84 M(+6.9%) |
Sep 2015 | - | $8.28 M(-13.0%) |
Jun 2015 | - | $9.51 M(-2.5%) |
Mar 2015 | - | $9.76 M(-15.2%) |
Dec 2014 | $11.50 M(-8.4%) | $11.50 M(+21.4%) |
Sep 2014 | - | $9.48 M(-5.5%) |
Jun 2014 | - | $10.03 M(-0.1%) |
Mar 2014 | - | $10.04 M(-20.1%) |
Dec 2013 | $12.56 M(-24.3%) | $12.56 M(-5.2%) |
Sep 2013 | - | $13.26 M(-9.8%) |
Jun 2013 | - | $14.71 M(-11.4%) |
Dec 2012 | $16.60 M | $16.60 M |
FAQ
- What is Evogene annual total liabilities?
- What is the all time high annual total liabilities for Evogene?
- What is Evogene annual total liabilities year-on-year change?
- What is Evogene quarterly total liabilities?
- What is the all time high quarterly total liabilities for Evogene?
- What is Evogene quarterly total liabilities year-on-year change?
What is Evogene annual total liabilities?
The current annual total liabilities of EVGN is $22.42 M
What is the all time high annual total liabilities for Evogene?
Evogene all-time high annual total liabilities is $22.42 M
What is Evogene annual total liabilities year-on-year change?
Over the past year, EVGN annual total liabilities has changed by +$1.08 M (+5.06%)
What is Evogene quarterly total liabilities?
The current quarterly total liabilities of EVGN is $27.88 M
What is the all time high quarterly total liabilities for Evogene?
Evogene all-time high quarterly total liabilities is $27.88 M
What is Evogene quarterly total liabilities year-on-year change?
Over the past year, EVGN quarterly total liabilities has changed by +$5.99 M (+27.39%)